Deutsches Krebsforschungszentrum - Senior Postdoc for the Division of Personalized Immunotherapies

apartmentDeutsches Krebsforschungszentrum (DKFZ) placeMainz calendar_month 
Research for a life without cancer” is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully.

Every contribution counts – whether in research, administration, or infrastructure. This is what makes our daily work so meaningful and exciting.

The Helmholtz Institute HI-TRON is a collaboration of the German Cancer Research Center (DKFZ) with the Research Institute for Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz (TRON gGmbH), the University Medical Center Mainz and the Johannes Gutenberg University Mainz.

The goal of the partnership is to develop effective immunotherapies and to identify novel biomarkers for assessing the effectiveness of treatment.

To strengthen the HI-TRON team in Mainz, we are seeking a skilled and motivated

Senior Postdoc for the Division of Personalized Immunotherapies

Reference number: 2024-0329
  • Mainz
  • Fulltime
  • HI-TRON Mainz – Personalized Immunotherapies
The Division of Personalized Immunotherapy (headed by Prof. Dr. Özlem Türeci) at HI-TRON Mainz is looking for a senior postdoc with a strong background in lipid nanoparticle (LNP) formulation and a passion for developing innovative platforms.

The successful candidate will be instrumental in advancing fundamental knowledge and creating novel technologies to enable cell-specific biomolecule delivery.

Your Tasks
  • Lead the development and optimization of LNP formulation for cell-specific biomolecule delivery, including high-throughput screening of lipid compositions and formulation parameters
  • Develop and apply methods for LNP purification and characterization
  • Apply in vitro and in vivo models to assess biodistribution, efficiency, toxicity, and cell-specific LNP uptake
  • Lead the development of LNP targeting strategies using ligand conjugation, peptides, or antibodies for cell / tissue-specific delivery
  • Present research findings internally and externally (national and international conferences) and publish in peer-reviewed scientific journals
  • Identify new research directions, develop grant proposals, and contribute to securing external funding
Your Profile
  • Master's degree and PhD in pharmaceutical sciences, chemistry, bio- or chemical engineering, or related fields
  • Extensive experience in LNP formulation methods, including hands-on experience with microfluidic devices, and targeted delivery strategies, including bioconjugation techniques
  • Deep knowledge in nanoparticle purification (e.g., size-exclusion chromatography, ultracentrifugation, and dialysis), and characterization (e.g., dynamic light scattering, and Cryo-EM)
  • Strong background in relevant in vitro and in vivo models and approaches for evaluating key parameters of nanoparticles, such as efficacy, biodistribution, and toxicity
  • Proven publication record in high-impact journals related to biological therapeutics and nanomedicine
  • Meticulous, quality-focused, and able to work independently while consistently meeting deadlines with a high degree of accuracy and efficiency
  • Strong written and oral communication skills in English with effective interpersonal skills that foster teamwork and collaboration
We Offer
  • Excellent framework conditions: state-of-the-art equipment and opportunities for international networking at the highest level
  • Remuneration according to TV-L incl. occupational pension plan and capital-forming payments
  • 30 days of vacation per year
  • Flexible working hours
  • Possibility of part-time work
  • Family-friendly working environment
  • Sustainable travel to work: subsidized Germany job ticket
  • Our Corporate Health Management Program offers a holistic approach to your well-being
  • Develop your full potential: access to the DKFZ International Postdoc Program and DKFZ Career Service with targeted offers for your personal development to further develop your talents
Contact: Dr. Ibrahim Murathan Sektioglu

Telefon: +49 6131 179816

The position is limited to 3 years with the possibility of prolongation.

Are you interested?

Then become part of the DKFZ and join us in contributing to a life without cancer!

Apply now

We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age.

People with severe disabilities are given preference if they have the same aptitude.

Notice: We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.

Share this job!

Deutsches Krebsforschungszentrum | Im Neuenheimer Feld 280 | 69120 Heidelberg | www.dkfz.de

apartmentDeutsches KrebsforschungszentrumplaceMainz
effectiveness of treatment. To strengthen the HI-TRON team in Mainz, we are seeking a skilled and motivated The Division of Personalized Immunotherapy (headed by Prof. Dr. Özlem Türeci) at HI-TRON Mainz is looking for a senior postdoc with a strong background...
apartmentInstitut für Molekulare Biologie gGmbHplaceMainz
About us IMB (www.imb.de) is a research institute on the campus of the Johannes Gutenberg University in Mainz, Germany. It is generously funded by the Boehringer Ingelheim Foundation and the state of Rhineland-Palatinate. Our research focuses on the...
apartmentJohannes Gutenberg-Universität MainzplaceMainz
and evolutionary conflicts. We are therefore offering two postdoctoral positions. Both positions are offered for 3 years, ideally starting in January 2025 (with considerable flexibility). You will join a research group that will offer collaboration prospects...